相关实验视频
Updated: Feb 18, 2026

09:09
In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
2.3K
用人工智能支持的临床决策支持系统对冠状动脉再血管化的健康经济模拟建模
Tom Mullie1, Arjun Puri2,3, Emma Bogner2,3
1Acute Care Alberta, Calgary, AB, Canada.
NPJ digital medicine
|February 16, 2026
概括
人工智能 (AI) 决策支持系统可以优化冠状动脉复血管化治疗. 这种人工智能工具证明了冠状动脉疾病患者的显著成本节约和改善质量调整寿命年 (QALYs).
科学领域:
- 心血管医学 心血管医学
- 卫生经济学 卫生经济学
- 医疗保健中的人工智能
背景情况:
- 对人工智能用于冠状动脉再血管化的决策支持的健康经济评估很少.
- 人工智能模型在指导冠状动脉疾病的治疗选择方面表现有前途.
研究的目的:
- 评估人工智能支持的冠状动脉再血管化的决策支持系统的健康经济价值.
- 评估人工智能对治疗决策,成本和患者结果的影响.
主要方法:
- 追溯健康经济模拟建模研究.
- 利用了25942名患有阻塞性冠状动脉疾病的成年患者的现实数据.
- 模拟人工智能对主要不良心血管事件和死亡率的预测,以指导治疗决策 (医疗疗法,PCI,CABG).
主要成果:
- 高达72.4%的治疗决策转向了以人工智能支持的健康经济优化的选择.
- 平均节省了22,960美元的成本,每名患者的QALY获利高达22,439美元.
- 即使在AI采用有限的情况下,53.2%的决策也被转移,每位患者的QALY收益高达32.214美元.
结论:
- 人工智能支持的决策支持可以显著优化冠状动脉复血管化策略的经济价值.
- 人工智能的实施可以通过减少并发症和改善患者的结果来降低医疗保健成本.
- 人工智能有可能提高医疗系统在心血管治疗决策中的效率.
更多相关视频
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
971
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
4.6K
相关概念视频
Coronary Artery Disease V: Interprofessional Care
307
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
307
Acute Coronary Syndrome IV: Interprofessional Care
313
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
313